H.C. Wainwright reaffirmed its Buy rating and $25.00 stock price target for Cabaletta Bio Inc . (NASDAQ:CABA), which currently trades at $2.43. The firm's analysis follows recent updates on the ...

Handa Therapeutics acquires US FDA approved chronic myeloid leukaemia drug, Phyrago tablets from Nanocopoeia: Taipei, Taiwan Friday, January 17, 2025, 15:00 Hrs [IST] Handa Pharma ...

Two Pennsylvania residents appeared in federal court, with one sentenced for his role in drug trafficking and the other ...

Two men pleaded guilty Wednesday to murder and racketeering charges in the March 2020 shooting death of a Philadelphia police ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In this article, we are going ...

The move comes nearly 35 years after the dye was barred from cosmetics such as lipsticks because of potential cancer risk.

The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...

Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...

The National Association of Chain Drug Stores is praising the Federal Trade Commission's (FTC) unanimous, 5-0, vote on Monday to release the second interim staff report on the FTC's study of big ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

PHYRAGO Represents the First and Only Improved Version of SPRYCEL® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceu ...